Predictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm Neonates

Recruiting Observational Study
Pre-Term Respiratory Distress of Newborn Premature
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
34 Weeks – 36 Weeks
Sex
Any
Study type
Observational
Participants needed
300 (estimated)
Sponsor
Hackensack Meridian Health · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Respiratory morbidity presents a significant clinical challenge in the neonatal period, and an individual patient's clinical course is often difficult to predict. This is especially true for late-preterm infants, who share some of the same risks of premature babies in terms or respiratory morbidity, but whose births may not always be attended by a neonatologist, or who may be born at hospitals wit…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Inborn infants born between 34w0d and 36w6d gestational age * In RA or 1 Litre per minute 1LPM NC (room air (RA) or nasal cannula (NC)) * Admitted to NICU or Well Baby Nursery (WBN) Exclusion Criteria: * Patients born \<34 weeks or \>36w6d * Major genetic anomaly or syndromi…
Contacts

Jeanette Haugh

551-996- 3457

Jeanette.Haugh@HMHN.org

CONTACT